1980
DOI: 10.1016/0021-9150(80)90095-7
|View full text |Cite
|
Sign up to set email alerts
|

Serum profile of non-esterified fatty acids (NEFA) in patients with hyperlipoproteinemia under xantinol-nicotinate (XN) medication

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1988
1988
2008
2008

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 27 publications
0
1
0
Order By: Relevance
“…As a result, Xanthinol Nicotinate has been used to treat peripheral vascular disorders, arteriosclerotic conditions [2,3] cerebrovascular insufficiency [4], dementia [5] and hyperlipoproteinemia [6], etc. The absorption of two xanthinol nicotinate formulations has been reported by measuring plasma levels of nicotinic acid [7].…”
Section: Introductionmentioning
confidence: 99%